Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Comparing Olopatadine 0.1% Ophthalmic Solution With Hylo-Dual Ophthalmic Preparation in Children With Seasonal Allergic Conjunctivitis

NCT03186755 is registered in ClinicalTrials.gov with Michael Marchand, MD as lead sponsor.

NCT NCT03186755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03186755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Comparing Olopatadine 0.1% Ophthalmic Solution With Hylo-Dual Ophthalmic Preparation in Children With Seasonal Allergic Conjunctivitis
Lead sponsor
Michael Marchand, MD
Phase
Phase 4
Overall status
Unknown status
Start date
June 11, 2017
Completion date
December 31, 2024
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conjunctivitis, allergic, conjunctivitis, vernal